Intrapleural fibrinolytics for pleural infection: optimizing dosing for future trials.
Heppler
J Scott
JS
D001424:Bacterial Infections / Q000628:therapy*; D004322:Drainage / Q000379:methods*; D004334:Drug Administration Schedule; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006207:Half-Life; D006801:Humans; D015552:Injections, Intralesional; D010994:Pleura; D010995:Pleural Diseases / Q000382:microbiology* / Q000628:therapy; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator